Selexipag STADA

Medicinal product

(Invented) name

Selexipag STADA

Active substance (s)

Seleksipagas

Strength

400 µg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AC27, Selexipag

Marketing authorisation holder

STADA Arzneimittel AG, Vokietija

Date of authorisation

2025-11-27

Date of renewal

Documents

5900-07_pakuotes lapelis_2025-11-27.docx

5900-5907_Selexipag STADA.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/6182/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Seleksipagas	400 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119235	105339	1105339	lizdinė plokštelė	N60		Receptinis	LT/1/25/5901/001	Netiekiama	-	-	No	-	-
119236	105340	1105340	dalomoji lizdinė plokštelė	N60×1		Receptinis	LT/1/25/5901/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-11-27	Registruotas